Effectiveness of a bioactive food compound in anthropometric measures of individuals with HIV/AIDS: A nonrandomized trial

• Published in: PloS one Vol. 13; no. 2; p. e0191259
• Main Authors: Ferreira, Rosângela Dos Santos, Guimarães, Rita de Cássia Avellaneda, Pontes, Elenir Rose Jardim Cury, Mendonça, Lígia Aurélio Bezerra Maranhão, Freitas, Karine de Cássia, Hiane, Priscila Aiko
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 09-02-2018; Public Library of Science (PLoS)
• Subjects: Acquired immune deficiency syndrome; Adults; AIDS; Anthropometry; Antiretroviral agents; Antiretroviral drugs; Bioactive compounds; Biological activity; Biology and Life Sciences; Body composition; Body mass; Body mass index; Body measurements; Body size; Functional foods & nutraceuticals; Glucose metabolism; Highly active antiretroviral therapy; Hip; HIV; Human immunodeficiency virus; Lipid metabolism; Lipids; Medicine and Health Sciences; Metabolic disorders; Metabolic syndrome; Metabolism; Patients; Therapy; Viruses; Womens health; Brazil
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0191259

Highly Active Antiretroviral therapy (HAART) promotes anthropometric changes in lipid metabolism and glucose in patients with Human Immunodeficiency Virus (HIV). Functional foods play an important role on metabolism. Bioactive Food Compound (BFC) has shown effective results in changes arising from decompensated lipid metabolism due to the effects of HAART on HIV patients. From this perspective, the objective of this study is to evaluate anthropometric indicators and the body composition of patients undergoing HAART before and after consumption of BFC.
This is a prospective intervention with 180 individuals with HIV undergoing HAART. They formed two groups and were monitored for 3 months: the first group consisted of individuals who consumed BFC (n = 121) at the recommended daily intake of 40 g. The second group consisted of individuals who did not consume BFC (n = 59). We determined body mass index (BMI), waist circumference (WC), waist-hip ratio (WHR), conicity index (CI) and antiretroviral regimen used by the patients.
The BMI among adults (p<0.001), the WC (p<0.001 and p<0.014 for men and women, respectively) and the CI (p = 0.001 and p<0.001 for men and women, respectively) increased at the end of the study in the group of individuals who did not consume BFC and remained stable in the BFC group. There were no changes in WHR in any of the groups evaluated. Regarding the antiretroviral regimens used, we observed that there was no difference between regimens as for BMI, WC, WHR and CI.
The BFC consumed by HIV patients undergoing HAART allowed the maintenance of anthropometric measures without increasing the mean values of conicity index, suggesting that the consumption of this bioactive compound protects the individual against the development of metabolic syndrome (MeS) in patients infected with HIV undergoing antiretroviral therapy.